B9A.F 18.86 (-3.08%)
SE0010323311BiotechnologyBiotechnology

BioArctic (B9A.F) Stock Highlights

18.86 | -3.08%
2024-12-21 04:17:40
BioArctic AB is a research-based biopharmaceutical company. It is primarily focused on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimers disease and Parkinsons disease. In addition, the group is also focused on the development of a treatment with a combination of a biodegradable medical device and a drug substance for complete spinal cord injury. Geographically, it derives a majority of revenue from Asia.

Statistics

Range Today
18.86 19.18
Volume Today 1
Range 1 Year
11.94 24.84
Volume 1 Year 3.94K
Range 3 Year
6.16 32.06
Volume 3 Year 22.83K
Range 10 Year
4.27 32.06
Volume 10 Year 54.82K

Highlights

Market Capitalization 1.23B (small)
Floating Shares 52.53M
Current Price 18.86
Price To Earnings -143.67
Price To Revenue 2.38
Price To Book 1.23
Earnings Per Share -0.09
Payout Ratio 0%

Performance

Latest -3.08%
1 Month +22.23%
3 Months +26.92%
6 Months -0.16%
1 Year -20.56%
3 Years +71.77%
5 Years +108.63%
10 Years +182.12%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.